Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Alan Meds vs YourHealthRx

Alan Meds
Graded #99

Higher grade

vs+1.6999999999999886
YourHealthRx
Graded #131

Lower grade

The verdict

Alan Meds takes it — 71.1/100 to 69.4/100, but only just.

Alan Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth platform offering compounded semaglutide and tirzepatide with multiple administration formats including microdosing and oral options. YourHealthRx is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAlan Meds +20
72
52
Dose & formulationEven
75
75
Clinical oversightYourHealthRx +5
82
87
Labs & monitoringYourHealthRx +14
53
67
FulfillmentYourHealthRx +16
78
94
Contract termsAlan Meds +22
55
33
Alan Meds · left barYourHealthRx · right bar

The numbers

MetricAlan MedsYourHealthRx
WeighScore71.1/10069.4/100
GradeCC
Scorecard rank#99#131
Semaglutide$158/mo (compounded)$170/mo (compounded)
Tirzepatide$295/mo (compounded)$210/mo (compounded)
Coverage46 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Alan Meds

Graded #99 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access
  • Multiple administration formats

Where it loses points

  • Limited public information on program details
YourHealthRx

Graded #131 · C

Strengths

  • Available in all 50 states and DC through a multi-state (IMLC) licensed clinician network
  • Compounded semaglutide and tirzepatide in two formats - weekly injectable (with B12) or daily oral dissolving tablet
  • Flat subscription price that doesn't change as your dose increases (no titration penalty)
  • Science-forward, clinician-led, with built-in follow-up, lab testing, and a broad peptide and longevity catalog (BPC-157, TB-500, sermorelin, NAD+)
  • Transparent, education-first positioning with published medical disclaimer, privacy, and terms

Where it loses points

  • Eligibility and prescribing run through partner clinical workflows - YourHealthRx is the platform, not the prescriber or pharmacy
  • Compounded medications are not FDA-approved - not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • The compounding pharmacy partner is not named ('transparent sourcing' claimed but no pharmacy disclosed)
  • Headline prices include a first-month intro rate; ongoing monthly cost is higher (semaglutide ~$170, tirzepatide ~$210)
  • No LegitScript certification displayed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard